Ezetimib Plus Spirig HC 10/10 mg

Hauptinformation

  • Handelsname:
  • Ezetimib Plus Spirig HC 10/10 mg Tabletten
  • Darreichungsform:
  • Tabletten
  • Zusammensetzung:
  • ezetimibum 10 mg, simvastatinum 10 mg, antiox.: E 310, E 320, excipiens pro compresso.
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Ezetimib Plus Spirig HC 10/10 mg Tabletten
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Synthetika human
  • Therapiebereich:
  • Reduktion der Serumcholesterinkonzentration

Weitere Informationen

Status

  • Quelle:
  • Swissmedic - Swiss Agency for Therapeutic Products
  • Zulassungsnummer:
  • 66233
  • Berechtigungsdatum:
  • 10-10-2017
  • Letzte Änderung:
  • 02-02-2018

11-5-2018

FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

FDA approves Gilenya (fingolimod) to treat multiple sclerosis MS in children age 10 and older. This is the first FDA approval of a drug to treat MS in pediatric patients

FDA - U.S. Food and Drug Administration

11-5-2018

May 10, 2018: South Carolina Couple Sentenced to a Total of 138 Months in Prison for Trafficking Counterfeit Goods, Including Misbranded Pet Medicine

May 10, 2018: South Carolina Couple Sentenced to a Total of 138 Months in Prison for Trafficking Counterfeit Goods, Including Misbranded Pet Medicine

May 10, 2018: South Carolina Couple Sentenced to a Total of 138 Months in Prison for Trafficking Counterfeit Goods, Including Misbranded Pet Medicine

FDA - U.S. Food and Drug Administration

10-5-2018

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

May 10, 2018: Former New Hampshire Pharmacist Sentenced to Two Years in Prison for Drug-Related Offenses

FDA - U.S. Food and Drug Administration

10-5-2018

Medline Remedy Essentials No-Rinse Cleansing Foam: Avoid Using - Multistate Outbreak of Burkholderia Cepacia Complex

Medline Remedy Essentials No-Rinse Cleansing Foam: Avoid Using - Multistate Outbreak of Burkholderia Cepacia Complex

CDC reports that there are 10 confirmed cases of infection caused by bacteria within the Burkholderia cepacia complex, also commonly called B. cepacia, in three states: California (2), Pennsylvania (7), and New Jersey (1). These patients were already hospitalized for acute conditions and acquired the infections while hospitalized. The infections have been linked to the Medline product, Remedy Essentials No-Rinse Cleansing Foam.

FDA - U.S. Food and Drug Administration

7-5-2018

Viibryd Starter Kit (10 & 20 mg)

Viibryd Starter Kit (10 & 20 mg)

Health Canada

10-7-2018

Raloxifene Teva (Teva B.V.)

Raloxifene Teva (Teva B.V.)

Raloxifene Teva (Active substance: Raloxifene hydrochloride) - Centralised - Yearly update - Commission Decision (2017)4939 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

14-5-2018

Aricept® 5 mg/10 mg

Rote - Liste

8-5-2018

OXALIS 10% ESSENCE Liquid [Uriel Pharmacy Inc.]

OXALIS 10% ESSENCE Liquid [Uriel Pharmacy Inc.]

Updated Date: May 8, 2018 EST

US - DailyMed

8-5-2018

OCALIVA® 5 mg / 10 mg Filmtabletten

Rote - Liste

7-5-2018

Night Sweats (In Men and Women) Causes, Remedies, and Treatments

Night Sweats (In Men and Women) Causes, Remedies, and Treatments

Title: Night Sweats (In Men and Women) Causes, Remedies, and TreatmentsCategory: Diseases and ConditionsCreated: 1/10/2006 12:00:00 AMLast Editorial Review: 5/7/2018 12:00:00 AM

US - MedicineNet

4-5-2018

Diaper Rash

Diaper Rash

Title: Diaper RashCategory: Diseases and ConditionsCreated: 11/10/1998 12:00:00 AMLast Editorial Review: 5/4/2018 12:00:00 AM

US - MedicineNet

4-5-2018

Femoston® 1 mg/10 mg Filmtabletten

Rote - Liste

4-5-2018

Femoston® 2/10 mg Filmtabletten

Rote - Liste

3-5-2018

AURUM 10 SPECIAL ORDER Liquid [Uriel Pharmacy Inc.]

AURUM 10 SPECIAL ORDER Liquid [Uriel Pharmacy Inc.]

Updated Date: May 3, 2018 EST

US - DailyMed

2-5-2018

Antinuclear Antibody Test

Antinuclear Antibody Test

Title: Antinuclear Antibody TestCategory: Procedures and TestsCreated: 10/17/1998 12:00:00 AMLast Editorial Review: 5/2/2018 12:00:00 AM

US - MedicineNet

2-5-2018

Gamunex 10% - Infusionslösung

Rote - Liste

1-5-2018

Take These 5 Steps to Live 10 Extra Years

Take These 5 Steps to Live 10 Extra Years

Title: Take These 5 Steps to Live 10 Extra YearsCategory: Health NewsCreated: 4/30/2018 12:00:00 AMLast Editorial Review: 4/30/2018 12:00:00 AM

US - MedicineNet

1-5-2018

STANNUM 10 SPECIAL ORDER Liquid [Uriel Pharmacy Inc.]

STANNUM 10 SPECIAL ORDER Liquid [Uriel Pharmacy Inc.]

Updated Date: May 1, 2018 EST

US - DailyMed

1-5-2018

01.05.2018: Atozet 10 mg / 10 mg, Filmtabletten, 30 Tablette(n), 63.05, -10.1%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer65223001 ZulassungsinhaberMSD Merck Sharp & Dohme AGNameAtozet 10 mg / 10 mg, FilmtablettenRegistrierungsdatum02.04.2015  Erstzulassung Sequenz01.04.2015ATC-KlassierungAtorvastatin and Ezetimibe (C10BA05)Revisionsdatum WHOWHO-DDDGültig bis01.04.2020Index Therapeuticus (BSV)07.12.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.12.Beschreibung AbgabekategorieB  SL EintragJaAnwendungPrimäre Hypercholesterinämie un...

ODDB -Open Drug Database

1-5-2018

01.05.2018: Atozet 10 mg / 10 mg, Filmtabletten, 90 Tablette(n), 156.40, -11.9%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer65223002 ZulassungsinhaberMSD Merck Sharp & Dohme AGNameAtozet 10 mg / 10 mg, FilmtablettenRegistrierungsdatum02.04.2015  Erstzulassung Sequenz01.04.2015ATC-KlassierungAtorvastatin and Ezetimibe (C10BA05)Revisionsdatum WHOWHO-DDDGültig bis01.04.2020Index Therapeuticus (BSV)07.12.Packungsgrösse90 Tablette(n)Index Therapeuticus (Swissmedic)07.12.Beschreibung AbgabekategorieB  SL EintragJaAnwendungPrimäre Hypercholesterinämie un...

ODDB -Open Drug Database

1-5-2018

01.05.2018: Atozet 10 mg / 20 mg, Filmtabletten, 30 Tablette(n), 63.05, -10.1%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer65223003 ZulassungsinhaberMSD Merck Sharp & Dohme AGNameAtozet 10 mg / 20 mg, FilmtablettenRegistrierungsdatum02.04.2015  Erstzulassung Sequenz01.04.2015ATC-KlassierungAtorvastatin and Ezetimibe (C10BA05)Revisionsdatum WHOWHO-DDDGültig bis01.04.2020Index Therapeuticus (BSV)07.12.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.12.Beschreibung AbgabekategorieB  SL EintragJaAnwendungPrimäre Hypercholesterinämie un...

ODDB -Open Drug Database